Translational models of brain activation patterns during nicotine self-administration and reinstatement
尼古丁自我给药和恢复过程中大脑激活模式的转化模型
基本信息
- 批准号:8869216
- 负责人:
- 金额:$ 16.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAmygdaloid structureAnteriorAreaAttenuatedAwardBehaviorBehavioralBrainBrain imagingBrain regionCardiovascular systemCessation of lifeChantixClinicalComplementCoupledCuesDataData AnalysesDetectionDevelopmentDiseaseDorsalDoseDrug AddictionDrug abuseDrug effect disorderExtinction (Psychology)FoundationsFundingFutureGeneral HospitalsGoalsHabenulaHandHypothalamic structureImageImage AnalysisImaging TechniquesInsula of ReilKnowledgeLaboratoriesLung diseasesMacacaMacaca mulattaMagnetic ResonanceMagnetic Resonance ImagingMalignant NeoplasmsMassachusettsMeasuresMediatingMentored Research Scientist Development AwardMentorsMethodologyModelingMusNeurobiologyNeuronsNeurosciences ResearchNicotineNicotine DependenceNucleus AccumbensPatternPharmaceutical PreparationsPhasePreparationProcessQualifyingRelapseResearchResearch PersonnelResearch Project GrantsResearch ProposalsResearch TrainingResolutionRewardsScientistSelf AdministrationSeriesSignal TransductionSocietiesStagingTestingThalamic structureTimeTrainingTraining ProgramsUnited StatesVentral Tegmental AreaWorkWritingaddictionawakebasecareercareer developmentcue reactivitydesigndrug of abusedrug reinforcementdrug relapseeconomic costeffective therapyexperienceinnovationinterpeduncular nucleusinvestigator trainingmanmeetingsmultidisciplinaryneural correlateneuroimagingnonhuman primatenovelpre-clinicalprogramspublic health relevancerelating to nervous systemresearch studyresponseskillssmoking cessationtooltreatment strategyvarenicline
项目摘要
DESCRIPTION (provided by applicant): Neuroimaging methodologies have become increasingly important tools in neuroscience research, providing a means for understanding the neural substrates related to drug action. This K01 Award will provide support and protected time for Dr. Stephen Kohut to obtain additional experience and mentoring that will complement and expand his existing expertise in preclinical IV drug self-administration and medication testing by acquiring new skills in pharmacologic magnetic resonance imaging (phMRI). During the proposed award period the PI will first complete an intensive training program to develop the core skills and knowledge necessary to design, conduct, and analyze phMRI studies. Training will occur at the McLean Imaging Center and Massachusetts General Hospital and will involve coursework and seminars, and discussions and meetings with a world-renowned mentoring team that will facilitate completion of an innovative research project. A major strength of the research project is that it will optimize the PI's training experience through a systematic series f experiments evaluating neuronal function during the phases of drug addiction typically modeled in the laboratory including IV self-administration (i.e., drug-taking) and reinstatement (i.e., relapse) and the effects of novel treatment approaches (pharmacological and/or behavioral) in non-human primates (NHP). Another major strength of the research plan, which will have a major impact on the field, is that it involves the use of awake, behaving NHP to study the functional consequences of nicotine self-administration and reinstatement and how they are altered during treatment. Functional brain activity in multiple brain regions will be directly relaed to ongoing "real time" behavior that can be measured within and across behavioral sessions. Focused research training in phMRI will occur at 3 Tesla (3T) through the Research Plan, but the PI will also receive training on a state-of-the-art, ultra-high field 9.4T magnet, large enough
to accommodate NHP. The combination of training at clinical field strength (3T) coupled with training at ultra-high field strength (9.4T) will equip the Candidate with the knowledge and skills
necessary to become an R01-funded independent investigator at the forefront of truly translational addiction research relating behavior and brain function. Overall, this training experience will allow the Candidate to develop a novel investigative approach for examining how novel treatments influence the various neuronal effects of nicotine and other drugs of abuse during periods of drug-taking and relapse, and will establish the PI as an independent scientist who is qualified to conduct highly translational addiction research that will address the
need for highly trained investigators who can explore the neural correlates of drug abuse and addiction.
描述(由申请人提供):神经影像学方法已成为神经科学研究中越来越重要的工具,为了解与药物作用相关的神经底物提供了一种手段。该K 01奖将为Stephen Kohut博士提供支持和保护时间,以获得额外的经验和指导,通过获得药理学磁共振成像(phMRI)的新技能,补充和扩展他在临床前IV药物自我管理和药物测试方面的现有专业知识。在拟定的奖励期间,PI将首先完成强化培训计划,以开发设计、实施和分析phMRI研究所需的核心技能和知识。培训将在姆克林成像中心和马萨诸塞州总医院进行,将涉及课程和研讨会,以及与世界知名的指导团队进行讨论和会议,这将有助于完成一个创新的研究项目。该研究项目的一个主要优势是,它将通过一系列系统的实验来优化PI的训练经验,这些实验评估了通常在实验室中建模的药物成瘾阶段期间的神经元功能,包括IV自我给药(即,服药)和恢复(即,复发)和新的治疗方法(药理学和/或行为)在非人灵长类动物(NHP)中的作用。 该研究计划的另一个主要优势将对该领域产生重大影响,它涉及使用清醒的行为NHP来研究尼古丁自我给药和恢复的功能后果以及它们在治疗期间如何改变。多个大脑区域的功能性大脑活动将与正在进行的“真实的时间”行为直接相关,这些行为可以在行为会话内和跨行为会话进行测量。通过研究计划,phMRI的重点研究培训将在3特斯拉(3 T)下进行,但PI也将接受最先进的超高场9.4T磁体的培训,该磁体足够大
以适应NHP。临床场强(3 T)培训与超高场强(9.4T)培训相结合,将使候选人具备以下知识和技能
有必要成为一个R 01资助的独立调查员在真正的翻译成瘾研究有关的行为和大脑功能的最前沿。总体而言,这种培训经验将使候选人能够开发一种新的研究方法,以检查新的治疗方法如何影响尼古丁和其他药物滥用在吸毒和复吸期间的各种神经元效应,并将使PI成为一名独立科学家,有资格进行高度转化的成瘾研究,
需要训练有素的调查人员,他们可以探索药物滥用和成瘾的神经相关性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen John Kohut其他文献
Stephen John Kohut的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen John Kohut', 18)}}的其他基金
Synthetic Psychoactive "Bath Salt" Effects on Brain Activity and Behavior
合成精神活性“浴盐”对大脑活动和行为的影响
- 批准号:
10359764 - 财政年份:2019
- 资助金额:
$ 16.4万 - 项目类别:
Synthetic Psychoactive "Bath Salt" Effects on Brain Activity and Behavior
合成精神活性“浴盐”对大脑活动和行为的影响
- 批准号:
10576883 - 财政年份:2019
- 资助金额:
$ 16.4万 - 项目类别:
Synthetic Psychoactive "Bath Salt" Effects on Brain Activity and Behavior
合成精神活性“浴盐”对大脑活动和行为的影响
- 批准号:
9913490 - 财政年份:2019
- 资助金额:
$ 16.4万 - 项目类别:
Translational models of brain activation patterns during nicotine self-administration and reinstatement
尼古丁自我给药和恢复过程中大脑激活模式的转化模型
- 批准号:
9249013 - 财政年份:2015
- 资助金额:
$ 16.4万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 16.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 16.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 16.4万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 16.4万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 16.4万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 16.4万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 16.4万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 16.4万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 16.4万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 16.4万 - 项目类别: